↓ Skip to main content

New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins

Overview of attention for book
Cover of 'New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 12 Downstream Processing Technologies/Capturing and Final Purification
  3. Altmetric Badge
    Chapter 14 Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective
  4. Altmetric Badge
    Chapter 18 Trends in Process Analytical Technology: Present State in Bioprocessing
  5. Altmetric Badge
    Chapter 19 Fully Disposable Manufacturing Concepts for Clinical and Commercial Manufacturing and Ballroom Concepts
  6. Altmetric Badge
    Chapter 20 High-Throughput Process Development for Biopharmaceuticals
  7. Altmetric Badge
    Chapter 38 Risk Mitigation in Preventing Adventitious Agent Contamination of Mammalian Cell Cultures
  8. Altmetric Badge
    Chapter 39 An Introduction to „Recent Trends in the Biotechnology Industry: Development and Manufacturing of Recombinant Antibodies and Proteins“
  9. Altmetric Badge
    Chapter 53 Gene Therapy
  10. Altmetric Badge
    Chapter 54 Manufacturing of Proteins and Antibodies: Chapter Downstream Processing Technologies
  11. Altmetric Badge
    Chapter 55 New Mammalian Expression Systems
  12. Altmetric Badge
    Chapter 56 Innovation in Cell Banking, Expansion, and Production Culture
  13. Altmetric Badge
    Chapter 57 Next Generation Biopharmaceuticals: Product Development
  14. Altmetric Badge
    Chapter 58 Continuous Manufacturing of Recombinant Therapeutic Proteins: Upstream and Downstream Technologies
  15. Altmetric Badge
    Chapter 59 A Different Perspective: How Much Innovation Is Really Needed for Monoclonal Antibody Production Using Mammalian Cell Technology?
Attention for Chapter 14: Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective
Chapter number 14
Book title
New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins
Published in
Advances in biochemical engineering biotechnology, May 2017
DOI 10.1007/10_2017_14
Pubmed ID
Book ISBNs
978-3-31-997108-7, 978-3-31-997110-0
Authors

Abraham, Eytan, Ahmadian, Behnam Baghbaderani, Holderness, Kathryn, Levinson, Yonatan, McAfee, Erika, Eytan Abraham, Behnam Baghbaderani Ahmadian, Kathryn Holderness, Yonatan Levinson, Erika McAfee

Abstract

As cell therapy processes mature from benchtop research protocols to industrial processes capable of manufacturing market-relevant numbers of doses, new cell manufacturing platforms are required. Here we give an overview of the platforms and technologies currently available to manufacture allogeneic cell products, such as mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs), and technologies for mass production of autologous cell therapies via scale-out. These technologies include bioreactors, microcarriers, cell separation and cryopreservation equipment, molecular biology tools for iPSC generation, and single-use controlled-environment systems for autologous cell production. These platforms address the challenges of manufacturing cell products in greater numbers while maintaining process robustness and product quality.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 67 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 18%
Researcher 11 16%
Student > Master 11 16%
Student > Bachelor 8 12%
Student > Doctoral Student 5 7%
Other 6 9%
Unknown 15 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 19%
Agricultural and Biological Sciences 9 13%
Engineering 8 12%
Immunology and Microbiology 5 7%
Chemical Engineering 3 4%
Other 13 19%
Unknown 17 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2017.
All research outputs
#15,460,734
of 22,974,684 outputs
Outputs from Advances in biochemical engineering biotechnology
#114
of 225 outputs
Outputs of similar age
#196,994
of 313,690 outputs
Outputs of similar age from Advances in biochemical engineering biotechnology
#4
of 6 outputs
Altmetric has tracked 22,974,684 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 225 research outputs from this source. They receive a mean Attention Score of 4.6. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,690 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.